Affordable Access

Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options.

Authors
  • Zapata, E1
  • Zubiaurre, L
  • Castiella, A
  • Salvador, P
  • García-Bengoechea, M
  • Esandi, P
  • Arriola, A
  • Beguiristain, A
  • Ruiz, I
  • Garmendia, G
  • Orcolaga, R
  • Alustiza, J M
  • 1 Deparment of Gastroenterology, Hospital de Mendaro, Barrio Mendarozabal, s/n. 20850 Mendaro, Gipúzcoa, Spain. [email protected] , (Spain)
Type
Published Article
Journal
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
Publication Date
Jul 01, 2010
Volume
102
Issue
8
Pages
484–488
Identifiers
PMID: 20670069
Source
Medline
License
Unknown

Abstract

current hepatocellular carcinoma surveillance programs, which comprise six-monthly ultrasonography and alpha-fetoprotein tests, are highly sensitive and effective. These programs result in the detection of hepatocellular carcinoma in its early-stages, when potentially curative treatment may be offered.

Report this publication

Statistics

Seen <100 times